Headlands Technologies’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,674
| Closed | -$6.24K | – | 1678 |
|
|
2024
Q3 | $6.24K | Buy |
+1,674
| New | +$6.24K | ﹤0.01% | 1052 |
|
|
2024
Q2 | – | Sell |
-6,641
| Closed | -$34.8K | – | 1701 |
|
|
2024
Q1 | $34.8K | Buy |
6,641
+2,861
| +76% | +$15K | 0.01% | 795 |
|
|
2023
Q4 | $19.8K | Buy |
3,780
+1,454
| +63% | +$7.6K | 0.01% | 668 |
|
|
2023
Q3 | $36.7K | Buy |
2,326
+1,686
| +263% | +$26.6K | 0.02% | 493 |
|
|
2023
Q2 | $12.4K | Buy |
+640
| New | +$12.4K | ﹤0.01% | 608 |
|